Channel Therapeutics Corporation
CHRO · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $36 | $277 | $277 | $277 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $2 | $1 | $1 | $1 |
| Enterprise Value | $37 | $278 | $277 | $278 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$3 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | -$7 | -$2 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$8 | -$7 | -$2 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.43 | -1.28 | -0.43 | -0.1 |
| % Growth | -11.7% | -197.7% | -330% | – |
| Operating Cash Flow | -$6 | -$1 | -$2 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6 | -$1 | -$2 | -$2 |